Reviews - Advarra

Phase I Oncology Clinical Trials

In a recent blog, we described the complexity and uniqueness of Phase I clinical trials, outlining the fact that some

A key element to successful study startup is identifying efficiencies to help meet critical milestones. Engaging with research compliance experts

Explore Advarra’s Study Activation Report to uncover roadblocks, survey findings, and solutions to streamline clinical trial activation at sites.

Discover how Meridian partnered with Advarra to ensure safety and streamline gene therapy research, including swift IBC approvals in just four days.

According to the Association for Clinical Oncology, individuals who identify as African American or Black make up 13.4% of the

With gene therapy trials on the rise, sites must prepare biosafety protocols, facility standards, and partnerships to attract cutting-edge studies.

In a recent webinar, Advarra regulatory experts presented on the topic titled Institutional Responsibilities Under a Federalwide Assurance (FWA). Our

In clinical research, working with organizations that understand the ins and outs of the phase of your trial is key

In the race to address the COVID-19 pandemic, researchers have worked tirelessly the past year to produce a vaccine. Operation

A common trope in sci-fi movies involves concerns about potentially smashing into uncharted objects while traveling at warp speed or

It’s safe to say 2020 has been more unpredictable than anyone could imagine. Through these unprecedented times, we have worked to provide the

FDA has recently issued guidance relating to changes for Certificates of Confidentiality (CoCs) brought about by the 21st Century Cures